Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
This intro highlights key habits to prevent budget mistakes and keep your spending aligned with your goals, offering actionable guidance for steady progress.
11,326 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Airgain's 2025 earnings outlook hinges on product mix, OEM momentum, and margin discipline. This guide breaks down th...
February delivered a sharp setback for AMZN as investors weighed another wave of capital spending against growth pros...
On a day when the market waded through tensions abroad and a stubborn oil rally, energy names bucked the trend. This ...
Three stocks mispriced right could offer substantial upside for patient investors. This article breaks down why these...
Two rising names—Oklo and Centrus Energy—are shaping the future of U.S. nuclear energy. This guide breaks down which ...
As software stocks wobble in 2026, one AI-first winner could rise from the noise. This article breaks down why a sele...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
A late-2025 Gallup poll finds only 28% of workers say now is a good time to find a quality job, with broad caution do...
When a marquee investor trims big tech bets, markets watch closely. This article explores cathie wood's invest dumps,...
Can Meta be a profitable addition to your portfolio? This guide weighs AI progress, cash flow, and valuation signals ...
The AI race keeps evolving, and Alphabet sits at the center. A rumored Anthropic cloud deal hints at how hyperscale i...